RU2001132334A - METHOD FOR IDENTIFICATION OF AN INDIVIDUAL IN WHICH THERE IS A RISK OF IRREVERSIBLE NEUROLOGICAL DAMAGES, INCLUDING STEPS OF QUANTITATIVE DETERMINATION OF THE PEPSINOGEN I12 (PG) CONCENTRATION - Google Patents
METHOD FOR IDENTIFICATION OF AN INDIVIDUAL IN WHICH THERE IS A RISK OF IRREVERSIBLE NEUROLOGICAL DAMAGES, INCLUDING STEPS OF QUANTITATIVE DETERMINATION OF THE PEPSINOGEN I12 (PG) CONCENTRATIONInfo
- Publication number
- RU2001132334A RU2001132334A RU2001132334/14A RU2001132334A RU2001132334A RU 2001132334 A RU2001132334 A RU 2001132334A RU 2001132334/14 A RU2001132334/14 A RU 2001132334/14A RU 2001132334 A RU2001132334 A RU 2001132334A RU 2001132334 A RU2001132334 A RU 2001132334A
- Authority
- RU
- Russia
- Prior art keywords
- concentration
- analyte
- individual
- vitamin
- pgi
- Prior art date
Links
- 108010047320 Pepsinogen A Proteins 0.000 title claims 7
- 230000002427 irreversible Effects 0.000 title claims 2
- 230000000926 neurological Effects 0.000 title claims 2
- 239000012491 analyte Substances 0.000 claims 7
- 210000002966 Serum Anatomy 0.000 claims 6
- 229930003779 Vitamin B12 Natural products 0.000 claims 6
- 125000003346 cobalamin group Chemical group 0.000 claims 6
- 239000011715 vitamin B12 Substances 0.000 claims 6
- 235000019163 vitamin B12 Nutrition 0.000 claims 6
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims 1
- 206010034695 Pernicious anaemia Diseases 0.000 claims 1
- ZIYVHBGGAOATLY-UHFFFAOYSA-L methylmalonate(2-) Chemical compound [O-]C(=O)C(C)C([O-])=O ZIYVHBGGAOATLY-UHFFFAOYSA-L 0.000 claims 1
Claims (5)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI990991 | 1999-04-30 | ||
FI990991A FI990991A (en) | 1999-04-30 | 1999-04-30 | Procedure for identifying an individual at risk of irreversible neurological damage |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001132334A true RU2001132334A (en) | 2003-08-27 |
RU2224258C2 RU2224258C2 (en) | 2004-02-20 |
Family
ID=8554566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001132334/15A RU2224258C2 (en) | 1999-04-30 | 2000-04-28 | Method for identifying person with the risk of non reversible neurological lesions including stages for quantitative detection of pepsinogen i (pg i) and vitamin b 12 concentrations |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1173764B1 (en) |
JP (1) | JP2002543430A (en) |
CN (1) | CN1353816A (en) |
AT (1) | ATE319088T1 (en) |
AU (1) | AU4299700A (en) |
DE (1) | DE60026285T2 (en) |
DK (1) | DK1173764T3 (en) |
ES (1) | ES2258453T3 (en) |
FI (1) | FI990991A (en) |
PT (1) | PT1173764E (en) |
RU (1) | RU2224258C2 (en) |
WO (1) | WO2000067029A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20010019A (en) * | 2001-01-05 | 2002-07-06 | Biohit Oyj | Procedure for the diagnosis of atrophic gastritis |
FI20065542A0 (en) * | 2006-09-01 | 2006-09-01 | Biohit Oyj | Method and Sampling Kit for Assessment of Abdominal Mucosal Condition |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI97304C (en) * | 1994-11-16 | 1996-11-25 | Locus Genex Oy | A method for screening for the risk of gastric cancer |
-
1999
- 1999-04-30 FI FI990991A patent/FI990991A/en unknown
-
2000
- 2000-04-28 PT PT00922683T patent/PT1173764E/en unknown
- 2000-04-28 AU AU42997/00A patent/AU4299700A/en not_active Abandoned
- 2000-04-28 AT AT00922683T patent/ATE319088T1/en not_active IP Right Cessation
- 2000-04-28 RU RU2001132334/15A patent/RU2224258C2/en active
- 2000-04-28 JP JP2000615816A patent/JP2002543430A/en active Pending
- 2000-04-28 EP EP00922683A patent/EP1173764B1/en not_active Expired - Lifetime
- 2000-04-28 WO PCT/FI2000/000376 patent/WO2000067029A1/en active IP Right Grant
- 2000-04-28 DE DE60026285T patent/DE60026285T2/en not_active Expired - Lifetime
- 2000-04-28 DK DK00922683T patent/DK1173764T3/en active
- 2000-04-28 ES ES00922683T patent/ES2258453T3/en not_active Expired - Lifetime
- 2000-04-28 CN CN00808519A patent/CN1353816A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60120487D1 (en) | METHOD FOR DETECTING VITAMIN D METABOLITES | |
WO2003043487A3 (en) | Method of using a non-antibody protein to detect and measure an analyte | |
EP1379693A4 (en) | Bio-barcodes based on oligonucleotide-modified particles | |
RU2002131152A (en) | COMPOSITIONS OF STABILIZED TETRAZOLIUM REAGENT AND WAYS OF THEIR APPLICATION | |
Caussé et al. | Plasma total homocysteine and other thiols analyzed by capillary electrophoresis/laser‐induced fluorescence detection: Comparison with two other methods | |
ATE230801T1 (en) | METHOD FOR DETECTING TARGET NUCLEIC ACID, METHOD FOR QUANTIFYING IT AND PYRYLIUM COMPOUNDS FOR CHEMILUMINESCENCE ANALYSIS | |
ATE556030T1 (en) | ULTRASENSITIVE DETECTION OF ANALYTES | |
SE9801563D0 (en) | Method of separation and kit to be used in the process | |
DK1371984T3 (en) | Chromatographic assay device and method for detecting the presence of an analyte in a whole blood sample | |
ATE479101T1 (en) | METHOD FOR QUANTIFYING DENATURATED LIPOPROTEIN | |
WO2004011607A3 (en) | Reagent and method for determination of a substance using an immunoaggregator | |
PT1173770E (en) | METHOD FOR ESTIMATING THE RISK OF PEPTIC ULCER | |
ATE309538T1 (en) | URINE DETERMINATION OF THE OVARIAN RESERVE | |
ATE331219T1 (en) | ANALYTICAL METHOD AND APPARATUS | |
DE69736336D1 (en) | METHOD FOR MEASURING BLOOD SUBSTANCES | |
WO2004001420A3 (en) | Method and reagent for specifically identifying and quantifying one or more proteins in a sample | |
HUP9800225A2 (en) | Process and compounds for use in detecting analytes by measurement of residual magnetism, and the use of the said compounds | |
RU2001132334A (en) | METHOD FOR IDENTIFICATION OF AN INDIVIDUAL IN WHICH THERE IS A RISK OF IRREVERSIBLE NEUROLOGICAL DAMAGES, INCLUDING STEPS OF QUANTITATIVE DETERMINATION OF THE PEPSINOGEN I12 (PG) CONCENTRATION | |
WO2002057793A3 (en) | Method of detecting prp protein and kits therefor | |
ATE354090T1 (en) | METHOD FOR DETERMINING CRP USING PHOSPHORYLCHOLINE | |
DE69529691D1 (en) | DIFFERENTIATED TIMING PROCEDURE FOR DETECTING MULTIPLE ANALYTES IN A TEST SAMPLE | |
DE60026285D1 (en) | METHOD FOR THE EVALUATION OF THE INDIVIDUAL RISK OF IRREVERSIBLE NERVE DAMAGE, WHICH INCLUDES STEPS FOR THE QUANTITATIVE DETERMINATION OF PEPSINOGEN I (PGI) AND VITAMIN B12 CONCENTRATIONS | |
RU2002107982A (en) | METHOD FOR IDENTIFICATION OF INDIVIDUAL WITH RISK OF VASCULAR AND CANCER DISEASES | |
JP2006522336A5 (en) | ||
DE50203136D1 (en) | Method for detecting analytes in samples by means of analytical elements |